Nuventra Pharma Sciences is now Allucent. Learn more here.

Take a deeper dive

News & Events

Nuventra Pharma Sciences Named to TBJ’s Fast 50 List

Nuventra Pharma Sciences, a specialized pharmaceutical consulting company with global reach, announces that it has been ranked as a part of the Triangle Business Journal‘s Fast 50 List honoring the 50 fastest growing privately held companies in the Triangle area. This honor follows three years of significant growth for the company. Nuventra’s growth has resulted from the ability to bring scientific expertise in drug development to pharma and biotech clients.

“We are honored to be included on this list. The growth we have experienced over the past few years is a testament to the expertise that our group is able to offer clients.”

“We look forward to continuing that growth as we remain the industry’s go-to resource for drug development consulting,” says Geoffrey C. Banks, Ph.D., Nuventra’s President and CEO.